Single-arm, non-randomized, prospective, multi-center study with the Bard® LifeStent® Vascular Stent Delivery. (BARD)

Grunddaten zu diesem Projekt

Beschreibung

In this study the Bard® LifeStent® Vascular Stent Delivery System is used in subjects with lifestyle-limiting claudication or ischemic rest pain that are candidates for percutaneous transluminal angioplasty (PTA) and stenting with lesion(s) in the infra-inguinal segment (superficial femoral artery (SFA) and/or proximal popliteal artey). Subjects will be treated with PTA followed by implantation of the Bard® LifeStent® Vascular Stent. Clinical follow-up for all subjects will be performed prior to hospital discharge, 30 days, 12-, 24-, and 36-months post index procedure.